Ultralife Corp (ULBI) stock
ULBINasdaqMiscellaneous Electrical Machinery, Equipment & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/30105% above fair value
$15.73−0.05 (-0.32%)
Close on Nov 13, 2026Market cap $262.11MP/E –Yield –
Ultralife EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Ultralife's EPS for the twelve months ending Sep 30, 2023 was $0.13. For fiscal 2025 it was -$35.00, down 192.1% from the year before. The highest annual figure on record is $38.00 in fiscal 2024.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$35.00 | -192.1% |
| FY2024 | Dec 31, 2024 | $38.00 | +8536.4% |
| FY2023 | Dec 31, 2023 | $0.44 | +780.0% |
| FY2022 | Dec 31, 2022 | $0.05 | 0.0% |
| FY2021 | Dec 31, 2021 | $0.05 | -84.8% |
| FY2020 | Dec 31, 2020 | $0.33 | -99.0% |
| FY2019 | Dec 31, 2019 | $32.00 | +1991.5% |
| FY2018 | Dec 31, 2018 | $1.53 | +218.8% |
| FY2017 | Dec 31, 2017 | $0.48 | +108.7% |
| FY2016 | Dec 31, 2016 | $0.23 | +35.3% |
| FY2015 | Dec 31, 2015 | $0.17 | – |
| FY2013 | Dec 31, 2013 | -$0.05 | – |
| FY2012 | Dec 31, 2012 | -$0.09 | – |
| FY2011 | Dec 31, 2011 | -$0.12 | – |
| FY2010 | Dec 31, 2010 | -$0.36 | – |
| FY2009 | Dec 31, 2009 | -$0.54 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $0.14 | -97.2% |
| Q2 FY2026 | Jun 30, 2026 | $15.00 | +36.4% |
| Q1 FY2026 | Mar 31, 2026 | -$3.00 | -15100.0% |
| Q3 FY2025 | Sep 30, 2025 | -$0.07 | -138.9% |
| Q2 FY2025 | Jun 30, 2025 | $5.00 | +6150.0% |
| Q1 FY2025 | Mar 31, 2025 | $11.00 | +13650.0% |
| Q3 FY2024 | Sep 30, 2024 | $0.02 | -33.3% |
| Q2 FY2024 | Jun 30, 2024 | $0.18 | +500.0% |
| Q1 FY2024 | Mar 31, 2024 | $0.08 | – |
| Q3 FY2023 | Sep 30, 2023 | $0.08 | +166.7% |
| Q2 FY2023 | Jun 30, 2023 | $0.03 | 0.0% |
| Q1 FY2023 | Mar 31, 2023 | $0.03 | – |
| Q4 FY2022 | Dec 31, 2022 | -$0.01 | -120.0% |
| Q3 FY2022 | Sep 30, 2022 | $0.03 | -40.0% |
| Q2 FY2022 | Jun 30, 2022 | $0.03 | -99.3% |
| Q1 FY2022 | Mar 31, 2022 | -$0.01 | -100.3% |
| Q3 FY2021 | Sep 30, 2021 | $0.05 | -99.5% |
| Q2 FY2021 | Jun 30, 2021 | $0.05 | -99.3% |
| Q1 FY2021 | Mar 31, 2021 | $4.00 | -33.3% |
| Q3 FY2020 | Sep 30, 2020 | $3.00 | -78.6% |
| Q2 FY2020 | Jun 30, 2020 | $10.00 | +33233.3% |
| Q1 FY2020 | Mar 31, 2020 | $7.00 | +473.8% |
| Q3 FY2019 | Sep 29, 2019 | $6.00 | +6566.7% |
| Q2 FY2019 | Jun 30, 2019 | $14.00 | +13900.0% |
| Q1 FY2019 | Mar 31, 2019 | $0.03 | -76.9% |
| Q4 FY2018 | Dec 31, 2018 | $1.22 | +1642.9% |
| Q3 FY2018 | Sep 30, 2018 | $0.09 | +28.6% |
| Q2 FY2018 | Jul 1, 2018 | $0.10 | -9.1% |
| Q1 FY2018 | Apr 1, 2018 | $0.13 | +18.2% |
| Q3 FY2017 | Oct 1, 2017 | $0.07 | – |
| Q2 FY2017 | Jul 2, 2017 | $0.07 | – |
| Q1 FY2017 | Apr 2, 2017 | $0.11 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.11 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?